Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.07.2023 | Case report

Dexamethasone/elasomeran/tozinameran

Hypomegakaryocytic thrombocytopenia, leukocytosis and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kobayashi M, et al. New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination. International Journal of Hematology : Jan 2023. Available from: URL: http://doi.org/10.1007/s12185-023-03618-7 Kobayashi M, et al. New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination. International Journal of Hematology : Jan 2023. Available from: URL: http://​doi.​org/​10.​1007/​s12185-023-03618-7
Metadaten
Titel
Dexamethasone/elasomeran/tozinameran
Hypomegakaryocytic thrombocytopenia, leukocytosis and lack of efficacy: case report
Publikationsdatum
01.07.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-42267-6

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Remdesivir

Case report

Rifampicin

Case report

Antineoplastics

Case report

Multiple drugs

Case report

Pembrolizumab